David Cohen
Pulmonary Disease · Chevy Chase, MDNPI 1710960794
Payments from drug & device makers
Across 224 payments — averaging $19.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$1K
- Boehringer Ingelheim$377
- Insmed, Inc.$265
- Bayer$216
- Mylan Specialty L.p.$195
- plus $1K from 21 others
What the payments were for
- Food & beverage$4,297100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 61 | $1,144 |
| GSK | 62 | $1,031 |
| Boehringer Ingelheim | 19 | $377 |
| Insmed, Inc. | 15 | $265 |
| Bayer | 9 | $216 |
| Mylan Specialty L.p. | 9 | $195 |
| Regeneron Healthcare Solutions, Inc. | 7 | $163 |
| TG Therapeutics, Inc. | 1 | $123 |
| Grifols USA, LLC | 5 | $98 |
| Sanofi | 4 | $92 |
| Paratek Pharmaceuticals, Inc. | 4 | $89 |
| Genentech USA, Inc. | 3 | $71 |
| Sunovion Pharmaceuticals Inc. | 5 | $69 |
| Advanced Respiratory, Inc | 3 | $63 |
| Vapotherm Inc | 2 | $43 |
| Gilead | 2 | $42 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Shionogi Inc | 1 | $31 |
| Philips North America LLC | 2 | $26 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| AbbVie | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| United Therapeutics Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BRIUMVI$123
How this compares
$4,312 in reported general payments places this provider in the 60th percentile of 297 pulmonary disease providers in Maryland.
Other pulmonary disease in Chevy Chase
- Carlos PiconeChevy Chase$89K
- Richard BernsteinAnnapolis$5.7M
- Alan SchwartzBaltimore$1.6M
- Sonye DanoffBaltimore$1.5M
- Michael DrummondBaltimore$1.4M
- da Wei LiaoBethesda$1.3M
- Paul HassounBaltimore$1.3M
- Lonny YarmusBaltimore$1.2M
- Jonathan SevranskyBaltimore$971K
- Robert ChasseSalisbury$788K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.